Su1251 CAN CAPSULE SPONGE (CYTOSPONGE/ENDOSIGN) BE INCORPORATED SAFELY INTO BARRETT'S SURVEILLANCE PROGRAMME? RETROSPECTIVE ASSESSMENT OF BARRETT'S DYSPLASIA PATTERNS SPANNING A 6-YEAR DURATION AT A SINGLE SECONDARY CARE SITE.
Gastroenterology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要